TCR Engineered T-Cell Therapy Market Report 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders … – Business Wire (press release)
|
TCR Engineered T–Cell Therapy Market Report 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders …
Business Wire (press release) Both receptors deploy T-cells to target the tumor, but CAR T-cells (CAR-T) are limited to binding to cell surface antigens, while TCR T-cells (TCR-T) recognize peptides (derived from intracellular proteins) presented on the cell surface by the major … |
